ROSA-BJORKESON DAGMAR 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed May 25, 2023
Insider Transaction Report
Form 4
ROSA-BJORKESON DAGMAR
Director
Transactions
- Award
Common Stock
2023-05-24+8,111→ 26,391 total - Award
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 totalExercise: $9.17Exp: 2033-05-24→ Common Stock (12,547 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2024 Annual Meeting of Stockholders.
- [F2]All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2024 Annual Meeting of Stockholders.